Source:http://linkedlifedata.com/resource/pubmed/id/20683266
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2010-8-12
|
| pubmed:abstractText |
The success of combined antiretroviral therapy (cART) has transformed HIV infection into a survivable chronic disease in developed countries. Increasingly then, the risks of HIV associated cancers become paramount. Burkitt lymphoma is one of the cancer subtypes highly disproportionately affecting HIV infected patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
1531-703X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
443-8
|
| pubmed:meshHeading |
pubmed-meshheading:20683266-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:20683266-Anti-Retroviral Agents,
pubmed-meshheading:20683266-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20683266-Burkitt Lymphoma,
pubmed-meshheading:20683266-Clinical Trials as Topic,
pubmed-meshheading:20683266-HIV,
pubmed-meshheading:20683266-Humans,
pubmed-meshheading:20683266-Lymphoma, AIDS-Related
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Controversies in the treatment of Burkitt lymphoma in AIDS.
|
| pubmed:affiliation |
Hematology Division, Lymphoma Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. noya@mskcc.org
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|